| PERIOD ENDING | 28-Jun-08 | 29-Mar-08 | 29-Dec-07 | 29-Sep-07 | | Total Revenue | 9,470,000 | 9,673,000 | 10,712,000 | 10,090,000 | | Cost of Revenue | 4,221,000 | 4,466,000 | 4,486,000 | 4,919,000 | | | Gross Profit | 5,249,000 | 5,207,000 | 6,226,000 | 5,171,000 | | | Operating Expenses | | Research Development | 1,468,000 | 1,467,000 | 1,481,000 | 1,521,000 | | Selling General and Administrative | 1,430,000 | 1,349,000 | 1,462,000 | 1,378,000 | | Non Recurring | 96,000 | 329,000 | 234,000 | 125,000 | | Others |
-
|
-
| 2,000 | 3,000 | | | | Total Operating Expenses |
-
|
-
| 3,179,000 | 3,027,000 | | | | Operating Income or Loss | 2,255,000 | 2,062,000 | 3,047,000 | 2,144,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 66,000 | 109,000 | 393,000 | 216,000 | | Earnings Before Interest And Taxes | 2,321,000 | 2,171,000 | 3,264,000 | 2,508,000 | | Interest Expense | 8,000 |
-
| 3,000 | 5,000 | | Income Before Tax | 2,313,000 | 2,171,000 | 3,261,000 | 2,503,000 | | Income Tax Expense | 712,000 | 728,000 | 990,000 | 712,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,601,000 | 1,443,000 | 2,271,000 | 1,791,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,601,000 | 1,443,000 | 2,271,000 | 1,791,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,601,000 | $1,443,000 | $2,271,000 | $1,791,000 |
|
7.87% Nasdaq 
Income Statement
